TENAX THERAPEUTICS, INC. — Key Metrics
10 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-1
Book Value Per Share
$2
Free Cash Flow Per Share
$-1
Cash Per Share
$2
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity↑+676.6pts
-55.6%
Return on Assets↑+452.6pts
-52.4%
Return on Invested Capital↑+535.8pts
-47.1%
Current Ratio↑+300.4% +$11
14.56
Quick Ratio↑+300.4% +$11
14.56
Asset Turnover↓-100.0% -$0
0.00
Days Sales Outstanding
—
Days Payables Outstanding
—
Days Inventory On Hand
—
Cash Conversion Cycle
—
R&D / Revenue
2649883.5%
SBC / Revenue
—
Capex / Revenue
553.4%
Working Capital↑+2253.2% +$93M
$97M
Net Current Asset Value↑+2362.8% +$93M
$97M
Invested Capital↑+2186.9% +$93M
$97M
OCF / Net Income↑+103.6% +$0
0.68
FCF / Net Income↑+103.5% +$0
0.68
Accruals Ratio (Sloan)↑+344.7pts
-16.1%
Net Debt↓-1647.9% -$92M
$-98M
Net Debt / EBITDA↑+914.4% +$2
1.73
Interest Coverage↓-114.0% -$7K
-847.57
Cash Coverage↑+88.7% +$5K
-643.96
Capex Coverage↓-577.1% -$4K
-4902.53
Tangible Common Equity↑+2186.9% +$93M
$97M
TCE / Total Assets↑+22.3pts
93.1%
Goodwill / Total Assets
0.0%
NOPAT↓-72.3% -$19M
$-45M
Cash ROIC↑+207.0pts
-37.9%
WC / Revenue
434670.4%
Capex / D&A↓-46.4% -$0
0.45
Reinvestment Rate↑+0.0pts
0.0%
Asset Growth vs Revenue Growth
28.9%
Revenue 5Y CAGR
-49.4%
Book Value 5Y CAGR↑+108.2pts
83.8%
Stock Price (FY-end)↓-99.3% -$2K
$12
Market Cap
$478M
P/S Ratio
—
P/B Ratio
4.92
P/TB Ratio
4.92
Enterprise Value
$380M
EV / Sales
—
FCF Yield
-7.5%
Shareholder Yield
-4.0%
R&D Yield
6.8%
Capex Yield
—
Operating Leverage
0.07
Shares Variation (YoY)
156.8%
Beta (5Y)↓-33.1% -$0
0.45
Cost of Equity↓-1.1pts
6.8%
52W High↓-99.7% -$4K
$13
52W Low↓-99.7% -$2K
$5
Trailing Return 1Y↑+137.6pts
93.5%
Trailing Return 5Y↓-2.0pts
-99.3%
F-Score (Piotroski)↓-50.0% -$1
1.00
Z-Score (Altman)
34.48
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.